Fig. 4From: Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 casesa The number of exacerbations per year for each patient b The mean exacerbation/hospitalization frequency per year, one year prior to omalizumab and annually thereafterBack to article page